TOP 5 MOST VIEWED NEWSREELS OF 2015 in Oncology

  1. TOP 5 MOST VIEWED NEWSREELS OF 2015 in Oncology
At the 2015 European Cancer Congress, Michel Ducreux, MD, PhD, of the Institut Gustave Roussy, discusses the efficacy and safety in the phase II COLO-001 study of nab-paclitaxel in patients with previously treated metastatic colorectal cancer.

WELL TOLERATED NEW CLASS  FOR COLON CA

At the 2015 ASCO Annual Meeting, Luis G. Paz-Ares, MD, PhD, of the Hospital Universitario Doce De Octubre, discusses the superior overall survival in patients taking nivolumab vs docetaxel in advanced nonsquamous non–small cell lung cancer .MONOCLONAL ANTIBODIES, LEASS TOXIC AND MORE EFFECTIVE
At the 2015 San Antonio Breast Cancer Symposium, Patricia A. Ganz, MD, of the University of California at Los Angeles, discusses a clinical trial of anastrozole vs tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy.  IT WAS BETTER At the 2015 ASCO Annual Meeting, Christopher Sweeney, MBBS, of Dana-Farber Cancer Institute, and Howard M. Sandler, MD, of Cedars-Sinai Medical Center, discuss the improvement of overall survival in localized, high-risk prostate cancer with the use of adjuvant chemotherapy following androgen suppression and radiotherapy. WAIT UNTIL IT IREALY IS TTME TO TREAT At the 2015 ASCO Annual Meeting, Brian I. Rini, MD, of the Cleveland Clinic Taussig Cancer Institute, discusses the results from a phase III study investigating a multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic renal cell carcinoma.

 

IMMUNOLOGIC THERPAY LEADS THE WAY INN ALSMOST AKK ASPECTS IN MELANOMA

. 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s